Mechanism of Action: Cytochrome P450 1A Inducers
✉ Email this page to a colleague
Drugs with Mechanism of Action: Cytochrome P450 1A Inducers
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Msn | ALBENDAZOLE | albendazole | TABLET;ORAL | 213435-001 | Jan 21, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Zydus Pharms | ALBENDAZOLE | albendazole | TABLET;ORAL | 208979-001 | Dec 14, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Actavis Elizabeth | ALBENDAZOLE | albendazole | TABLET;ORAL | 208094-001 | May 20, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |